Canada markets closed

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.1400-0.0600 (-5.00%)
At close: 04:00PM EDT
1.1400 0.00 (0.00%)
After hours: 07:44PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 87.66M
Enterprise Value 69.38M
Trailing P/E 13.33
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.51
Price/Book (mrq)2.61
Enterprise Value/Revenue 1.06
Enterprise Value/EBITDA 5.36

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 3-54.55%
S&P500 52-Week Change 324.19%
52 Week High 33.5500
52 Week Low 31.0900
50-Day Moving Average 31.3266
200-Day Moving Average 31.5641

Share Statistics

Avg Vol (3 month) 3370.55k
Avg Vol (10 day) 3407.65k
Shares Outstanding 573.05M
Implied Shares Outstanding 673.05M
Float 864.48M
% Held by Insiders 19.77%
% Held by Institutions 113.89%
Shares Short (Apr 15, 2024) 46.7M
Short Ratio (Apr 15, 2024) 416.98
Short % of Float (Apr 15, 2024) 49.43%
Short % of Shares Outstanding (Apr 15, 2024) 49.18%
Shares Short (prior month Mar 15, 2024) 46.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 20, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 12.69%
Operating Margin (ttm)-53.55%

Management Effectiveness

Return on Assets (ttm)9.32%
Return on Equity (ttm)72.50%

Income Statement

Revenue (ttm)65.49M
Revenue Per Share (ttm)0.97
Quarterly Revenue Growth (yoy)21.70%
Gross Profit (ttm)N/A
EBITDA 11.65M
Net Income Avi to Common (ttm)8.31M
Diluted EPS (ttm)0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.56M
Total Cash Per Share (mrq)0.61
Total Debt (mrq)26.28M
Total Debt/Equity (mrq)78.29%
Current Ratio (mrq)1.54
Book Value Per Share (mrq)0.46

Cash Flow Statement

Operating Cash Flow (ttm)-1.32M
Levered Free Cash Flow (ttm)-1.81M